Cue Biopharma, Inc. (CUE)

Cue Biopharma Revenue

In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth. Cue Biopharma had revenue of $21.94M in the quarter ending December 31, 2025, with 1,292.26% growth.

• Revenue (ttm): $27.47M
• Revenue Growth: +195.75%
• P/S Ratio: 3.47
• Revenue / Employee: $947,103
• Employees: 29
• Market Cap: 94.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	27.47M	18.18M	195.75%
Dec 31, 2024	9.29M	3.80M	69.16%
Dec 31, 2023	5.49M	4.25M	340.96%
Dec 31, 2022	1.25M	-13.70M	-91.67%
Dec 31, 2021	14.94M	11.79M	373.68%
Dec 31, 2020	3.15M	-304.00K	-8.79%
Dec 31, 2019	3.46M	2.32M	202.67%
Dec 31, 2018	1.14M	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-

Data Source: Fiscal.ai Last updated: Mar 16, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error